A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) Patients
Clinical trial NCT03407300 · UNKNOWN
Trial details
- NCT number
- NCT03407300
- Sponsor
- Haining Health-Coming Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2019-02-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.